GoodRx Holdings, Inc.
$2.37
▲
1.99%
2026-04-21 07:02:01
www.goodrx.com
NMS: GDRX
Explore GoodRx Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$811.9 M
Current Price
$2.37
52W High / Low
$5.81 / $1.77
Stock P/E
26.67
Book Value
$1.81
Dividend Yield
—
ROCE
7.56%
ROE
4.54%
Face Value
—
EPS
$0.09
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
697
Beta
1.47
Debt / Equity
88.08
Current Ratio
2.61
Quick Ratio
2.61
Forward P/E
5.96
Price / Sales
0.94
Enterprise Value
$1.03 B
EV / EBITDA
8.43
EV / Revenue
1.29
Rating
None
Target Price
$2.82
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 2. | HeartBeam, Inc. | $0.92 | — | $37.8 M | — | -812.1% | -9.87% | $4 / $0.54 | $0.07 |
| 3. | DarioHealth Corp. | $7.46 | — | $54.46 M | — | -36.38% | -59.62% | $17.74 / $5.93 | $9.84 |
| 4. | Heartflow, Inc. | $31.38 | — | $2.69 B | — | -20.2% | -1.11% | $41.22 / $20.13 | $3.52 |
| 5. | Omnicell, Inc. | $37.8 | 839.18 | $1.72 B | — | 0.34% | 0.17% | $55 / $22.66 | $27.36 |
| 6. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 7. | SCWorx Corp. | $1.05 | — | $1.18 M | — | -27.93% | -76.35% | $13.05 / $0.76 | $0.52 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 194.78 M | 196.03 M | 203.07 M | 202.97 M | 198.58 M | — |
| Operating Profit | 22.68 M | 14.62 M | 26.81 M | 23.38 M | 18.18 M | — |
| Net Profit | 5.42 M | 1.12 M | 12.84 M | 11.05 M | 6.74 M | — |
| EPS in Rs | 0.05 | 0.01 | 0.12 | 0.1 | 0.06 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 796.85 M | 792.32 M | 750.26 M | 766.55 M |
| Operating Profit | 87.49 M | 65.85 M | -27.01 M | 1.74 M |
| Net Profit | 30.44 M | 16.39 M | -8.87 M | -32.83 M |
| EPS in Rs | 0.28 | 0.15 | -0.08 | -0.3 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.4 B | 1.39 B | 1.59 B | 1.6 B |
| Total Liabilities | 787.8 M | 663.41 M | 826.84 M | 789.8 M |
| Equity | 616.26 M | 724.66 M | 761.96 M | 814.83 M |
| Current Assets | 643.1 M | 659.25 M | 872.79 M | 919.69 M |
| Current Liabilities | 246 M | 123.9 M | 122.56 M | 76.32 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 167.9 M | 183.89 M | 138.29 M | 146.78 M |
| Investing CF | -119.96 M | -70.35 M | -55.77 M | -210.5 M |
| Financing CF | -234.47 M | -337.5 M | -167.4 M | -120.23 M |
| Free CF | 93.88 M | 113.55 M | 82.53 M | 91.57 M |
| Capex | -74.02 M | -70.35 M | -55.77 M | -55.21 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 5.61% | -2.12% | — | — |
| Earnings Growth % | 284.82% | 72.99% | — | — |
| Profit Margin % | 2.07% | -1.18% | -4.28% | — |
| Operating Margin % | 8.31% | -3.6% | 0.23% | — |
| Gross Margin % | 93.91% | 91.08% | 91.51% | — |
| EBITDA Margin % | 19.43% | 14.5% | 8.5% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.